Average Co-Inventor Count = 3.12
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genvec, Inc. (18 from 88 patents)
2. The United States of America, As Represented by the Secretary, Department of Health and Human Services (2 from 3,539 patents)
3. Cornell University (1 from 2,885 patents)
4. Genvex, Inc. (1 from 1 patent)
20 patents:
1. 11359214 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use
2. 11034975 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
3. 10792376 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
4. 10787682 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use
5. 10640776 - Method for propagating adenoviral vectors encoding inhibitory gene products
6. 10272162 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
7. 10260074 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
8. 10059962 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use
9. 9725738 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
10. 9629906 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
11. 9617560 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use
12. 9580476 - Adenoviral vector-based respiratory syncytial virus (RSV) vaccine
13. 9388429 - Method for propagating adenoviral vectors encoding inhibitory gene products
14. 9233153 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
15. 8454972 - Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen